Adlai Nortye (ANL) Current Taxes (2023 - 2025)

Adlai Nortye's (ANL) quarterly Current Taxes came in at $18000.0 in Q4 2025, down 76.0% year-on-year from $75000.0 in Q4 2024, and down 76.0% on a QoQ basis from $75000.0 in Q4 2024.

Adlai Nortye (ANL) Current Taxes (2023 - 2025) Analysis & Trends

Adlai Nortye (ANL) has 3 years of Current Taxes data on file, last reported at $18000.0 in Q4 2025.

  • On a quarterly basis, Current Taxes fell 76.0% year-over-year to $18000.0 in Q4 2025; TTM through Dec 2025 was $18000.0, a 76.0% decrease from a year earlier, with the FY2025 full-year figure at $18000.0, down 76.0% from the prior year.
  • Current Taxes for Q4 2025 stood at $18000.0, down from $75000.0 in the prior quarter.
  • Over the last five years, Current Taxes for ANL reached as high as $130000.0 in Q4 2023 and fell as low as $18000.0 in Q4 2025.
  • Historically, Current Taxes has averaged $74333.3 across 3 years, with a median of $75000.0 in 2024.
  • Across the five-year window, Current Taxes sank 42.31% in 2024 and sank 76.0% in 2025, its largest moves.
  • Year by year, Current Taxes stood at $130000.0 in 2023, then sank by 42.31% to $75000.0 in 2024, then sank by 76.0% to $18000.0 in 2025.
  • Per Business Quant data, the three most recent Current Taxes figures were $18000.0 in Q4 2025, $75000.0 in Q4 2024, and $130000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 63.52 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 49.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Adlai Nortye 1.16 Bn 1.15 Bn - 18,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 18,000.00
Dec 31, 2024 75,000.00
Dec 31, 2023 130,000.00